Physician profile
Danny Cho
NPI 1043848443
$1,738.87
in general payments reported to CMS, 2019-2025
23 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $177 · 2023: $641 · 2024: $269 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,293 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,293.34 |
| Education | $268.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $474.28 | 2023-2025 | Avvigo Guidance System, Opticross 6, Watchman Access System |
| Abbott Laboratories | $293.58 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Medicure Pharma INC. | $153.13 | 2022 | |
| Abiomed | $127.79 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.90 | 2023-2025 | Lifevest |
| Heartflow, INC. | $51.62 | 2024-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $48.70 | 2023 | Arcalyst |
| Medtronic, INC. | $44.14 | 2023-2025 | Azure Xt Dr Mri Surescan |
| Cardiva Medical, INC. | $43.78 | 2023 | |
| Biotronik INC. | $39.91 | 2025 | |
| Edwards Lifesciences Corporation | $39.62 | 2023 | Sapien 3 Ultra Resilia |
| Zoll Circulation INC | $38.87 | 2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| E.R. Squibb & Sons, L.L.C. | $31.50 | 2023 | Camzyos |
| Amgen INC. | $31.04 | 2023 | Repatha |
| Cvrx, INC. | $29.91 | 2025 | Barostim Neo System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $26.70 | 2025 | Ecm Patch,Pouch |
| Daiichi Sankyo INC. | $26.48 | 2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.68 | 2025 | Jardiance |
| Gentuity, LLC | $25.44 | 2023 | Gentuity Hf-Oct Imaging System, Vis-Rx |
| Irhythm Technologies, INC. | $24.62 | 2024 | Zio Monitor, Zio Xt Patch |
| Masimo Corporation | $23.81 | 2022 | |
| Philips North America LLC | $22.10 | 2025 | Igt Devices Undivided |
| Astrazeneca Pharmaceuticals LP | $15.27 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.